Cecelia E. Gzell

Darlinghurst, NSW, Australia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

Dodecafluoropentane Emulsion as a Radiosensitizer in Glioblastoma Multiforme.

Dodecafluoropentane Emulsion as a Radiosensitizer in Glioblastoma Multiforme.

Journal: Cancer research communications
Published: December 27, 2022

Acetazolamide versus placebo for cerebral oedema requiring dexamethasone in recurrent and/or progressive high-grade glioma: phase II randomised placebo-controlled double-blind study.

Acetazolamide versus placebo for cerebral oedema requiring dexamethasone in recurrent and/or progressive high-grade glioma: phase II randomised placebo-controlled double-blind study.

Journal: BMJ supportive & palliative care
Published: December 07, 2022

Adult medulloblastoma in an Australian population.

Adult medulloblastoma in an Australian population.

Journal: Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia
Published: January 13, 2022

Optimal management in optic nerve sheath meningioma - A multicentre study and pooled data analysis.

Optimal management in optic nerve sheath meningioma - A multicentre study and pooled data analysis.

Journal: Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia
Published: March 14, 2020

Survival Outcomes of Elderly Patients With Glioblastoma Multiforme in Their 75th Year or Older Treated With Adjuvant Therapy.

Survival Outcomes of Elderly Patients With Glioblastoma Multiforme in Their 75th Year or Older Treated With Adjuvant Therapy.

Journal: International journal of radiation oncology, biology, physics
Published: November 02, 2016

Radiotherapy in Glioblastoma: the Past, the Present and the Future.

Radiotherapy in Glioblastoma: the Past, the Present and the Future.

Journal: Clinical oncology (Royal College of Radiologists (Great Britain))
Published: April 25, 2016

Small increases in enhancement on MRI may predict survival post radiotherapy in patients with glioblastoma.

Small increases in enhancement on MRI may predict survival post radiotherapy in patients with glioblastoma.

Journal: Journal of neuro-oncology
Published: April 30, 2015

Proliferation Index Predicts Survival after Second Craniotomy within 6 Months of Adjuvant Radiotherapy for High-grade Glioma.

Proliferation Index Predicts Survival after Second Craniotomy within 6 Months of Adjuvant Radiotherapy for High-grade Glioma.

Journal: Clinical oncology (Royal College of Radiologists (Great Britain))
Published: April 02, 2015

Large volume re-irradiation with bevacizumab is a feasible salvage option for patients with refractory high-grade glioma.

Large volume re-irradiation with bevacizumab is a feasible salvage option for patients with refractory high-grade glioma.

Journal: Neuro-oncology practice
Published: May 01, 2014

Elderly patients aged 65-75 years with glioblastoma multiforme may benefit from long course radiation therapy with temozolomide.

Elderly patients aged 65-75 years with glioblastoma multiforme may benefit from long course radiation therapy with temozolomide.

Journal: Journal of neuro-oncology
Published: November 07, 2013

Employment following chemoradiotherapy in glioblastoma: a prospective case series.

Employment following chemoradiotherapy in glioblastoma: a prospective case series.

Journal: Journal of cancer survivorship : research and practice
Published: August 22, 2013

Biopsy-proven brain metastases from prostate cancer: a series of four cases with review of the literature.

Biopsy-proven brain metastases from prostate cancer: a series of four cases with review of the literature.

Journal: International urology and nephrology
Published: February 17, 2013
Showing 1-12 of 13

Last Updated: 09/26/2026